Story · Medicine & Biotech

Short-Lived Hyperglycaemia Contributes to Continuous Glucose Monitoring Metrics Used for Therapeutic Decision-Making

1 outlet · first reported by medRxiv (all subjects) 13d ago

Coverage, in order

  1. 13d ago
    medRxiv (all subjects) obscure study
    Short-Lived Hyperglycaemia Contributes to Continuous Glucose Monitoring Metrics Used for Therapeutic Decision-Making

    Background: Continuous glucose monitoring (CGM) metrics, including time in range (TIR) and median glucose, guide therapeutic decisions in type 1 diabetes (T1D) but do not distinguish sustained from transient hyperglycaemia. We investigated the prevalence of short-lived hyperglycaemia (SLH), i.e…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.